Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
mpUS for Prostate Cancer Detection and Localization
NCT03101176Unknown
- Sponsor
- University of Amsterdam
- Start
- Sep 2017
- Primary completion
- Sep 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of sulfur hexafluoride in prostate cancer (PCa), sponsored by University of Amsterdam. Primary endpoint: Validation of mpUS at 5 years. Status: unknown.
02
Drugs
sulfur hexafluoride
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT03101176.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03101176.